SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 9 Apr · 18:09 IST

Shilpa Medicare Limited has informed the Exchange regarding 'initial disclosure of the Company identified as a Large Corporate '.

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹418.65
prior close
₹424.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.2-0.3-0.9-0.6-1.3-1.8-1.7-2.0-1.6+1.7+10.0+33.6+49.8
Up moveDown movePending
AI summary

Shilpa Medicare Limited has submitted an initial disclosure to stock exchanges (BSE and NSE) regarding its status as a Large Corporate under SEBI's framework for large entities issuing debt securities. The company has confirmed that it does NOT qualify as a Large Corporate as per the criteria laid out in the SEBI circular dated October 19, 2023. As of March 31, 2025, the company has nil outstanding long-term borrowings as defined under these SEBI circulars. Shilpa Medicare carries a credit rating of A+ with Positive Outlook from India Ratings & Research (Ind-Ra). Since the company does not fall under the Large Corporate category, no mandatory incremental borrowing obligations or potential fines apply to it.

Likely market impact

This is a routine SEBI compliance filing with no material impact on shareholders or the stock price. The nil long-term borrowings indicate a debt-free position under the SEBI definition, and the A+ Positive credit rating reflects a healthy credit profile.